Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
If overspending hit savings, concentrate on a concrete reset plan: set a short-term goal, cut a few costs, and automate a savings transfer to recover quickly.
24,735 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
The Shiba Inu project is under pressure after its official social channel sparked backlash with a controversial poll ...
Fixed notes are more than a loan term. They can be a proactive hedge against vacancy gaps. Learn how investors using ...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
Salesforce unveils a $50 billion buyback as software stocks waver, triggering a fierce debate over whether capital sh...
Two popular growth focused ETFs, VUG and MGK, battle for your attention. This guide breaks down how mega leaders broa...
Bitcoin, Ethereum and XRP lead a cautious rally as traders weigh regulatory momentum and macro risks. This story trac...
With market volatility on the rise, a $500 decision between XRP and precious metals can reshape your risk and growth ...
A new study shows a troubling planning gap among executives with equity awards. Despite financial savvy, 44% lack a f...
The Nasdaq may be hovering near a correction, but smart planning helps investors navigate volatility. Here are four e...
When top executives trim their holdings, investors pay attention. This article breaks down what a well timed trim mea...
This guide breaks down what Greenlight Re (GLRE) investors should watch in the first-quarter 2026 results. Learn how ...